Clinical Research Directory
Browse clinical research sites, groups, and studies.
Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
Sponsor: CHOSEOK YOON
Summary
This study aims to provide high-level evidence for appropriate empirical antibiotic use tailored to the clinical reality in Korea by conducting a randomized controlled trial comparing monotherapy with piperacillin/tazobactam and combination therapy with piperacillin/tazobactam plus a fluoroquinolone in patients with severe community-acquired pneumonia.
Official title: Verification of Anti-pseudomonal Antibiotic Combination Therapy in Severe Community-acquired Pneumonia in South Korea: A Randomized-controlled Study
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-06-15
Completion Date
2027-02-01
Last Updated
2025-05-18
Healthy Volunteers
No
Interventions
Piperacillin/Tazobactam
Piperacillin/tazobactam: 4.5g IV q6h (over 3h)
Piperacillin/tazobactam + Levofloxacin
Piperacillin/tazobactam: 4.5g IV q6h (over 3h) \+ Levofloxacin 750mg IV q24h (over 30min)
Locations (1)
Hanyang University Seoul Hospital
Seoul, Seoul, South Korea